{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T06:27:33Z","timestamp":1793600853545,"version":"4.5.0"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2023ZD0509000"],"award-info":[{"award-number":["2023ZD0509000"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.diabres.2026.113210","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T16:07:53Z","timestamp":1773158873000},"page":"113210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Microvascular disease beyond diabetes: a metabolic continuum with implications for early detection and diabetes care"],"prefix":"10.1016","volume":"235","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0950-9615","authenticated-orcid":false,"given":"Xiaohan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanhu","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongzhi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1865-1429","authenticated-orcid":false,"given":"Zilin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2026.113210_b0005","first-page":"1","article-title":"Microvascular complications and its predictors among type 2 diabetes mellitus patients at Dessie town hospitals","volume":"13","author":"Seid","year":"2021","journal-title":"Ethiopia Diabetology & Metabolic Syndrome"},{"issue":"12","key":"10.1016\/j.diabres.2026.113210_b0010","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.3390\/medicina57121380","article-title":"Microvascular complications, peripheral artery disease and mortality in patients with type 2 diabetes mellitus, in two counties of southern Lithuania over 13 years: analysis using a cohort database of the national health insurance","volume":"57","author":"Piliponien\u0117","year":"2021","journal-title":"Medicina"},{"issue":"8","key":"10.1016\/j.diabres.2026.113210_b0015","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.2337\/dc20-0072","article-title":"Health care costs associated with macrovascular, microvascular, and metabolic complications of type 2 diabetes across time: estimates from a population-based cohort of more than 0.8 million individuals with up to 15 years of follow-up","volume":"43","author":"Chen","year":"2020","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.diabres.2026.113210_b0020","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41392-023-01400-z","article-title":"Diabetic vascular diseases: molecular mechanisms and therapeutic strategies","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.diabres.2026.113210_b0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s13167-023-00314-8","article-title":"Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications\u2014risks and mitigation","volume":"14","author":"Kropp","year":"2023","journal-title":"Epma Journal"},{"issue":"1","key":"10.1016\/j.diabres.2026.113210_b0030","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2337\/dc20-1913","article-title":"Worldwide epidemiology of diabetes-related end-stage renal disease, 2000\u20132015","volume":"44","author":"Cheng","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2026.113210_b0035","article-title":"Peripheral arterial disease, foot ulcers, lower extremity amputations","author":"Boyko","year":"2021","journal-title":"and diabetes"},{"key":"10.1016\/j.diabres.2026.113210_b0040","article-title":"Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications","volume":"15","author":"Yang","year":"2024","journal-title":"Front Endocrinol"},{"issue":"15","key":"10.1016\/j.diabres.2026.113210_b0045","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.3390\/nu14153086","article-title":"Advanced glycation end products and their effect on vascular complications in type 2 diabetes mellitus","volume":"14","author":"Lee","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.diabres.2026.113210_b0050","doi-asserted-by":"crossref","unstructured":"Group UPDS: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). The Lancet 1998, 352(9131):854-865.","DOI":"10.1016\/S0140-6736(98)07037-8"},{"key":"10.1016\/j.diabres.2026.113210_b0055","doi-asserted-by":"crossref","unstructured":"Group AC: Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. New England journal of medicine 2008, 358(24):2560-2572.","DOI":"10.1056\/NEJMoa0802987"},{"issue":"14","key":"10.1016\/j.diabres.2026.113210_b0060","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Control","year":"1993","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.diabres.2026.113210_b0065","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1016\/j.ophtha.2014.07.019","article-title":"The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study","volume":"121","author":"Chew","year":"2014","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.diabres.2026.113210_b0070","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/oby.23222","article-title":"Microvascular differences in individuals with obesity at risk of developing cardiovascular disease","volume":"29","author":"van der Velden","year":"2021","journal-title":"Obesity"},{"issue":"4","key":"10.1016\/j.diabres.2026.113210_b0075","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/ATVBAHA.114.304591","article-title":"Metabolic syndrome individuals with and without type 2 diabetes mellitus present generalized vascular dysfunction: cross-sectional study","volume":"35","author":"Walther","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"21","key":"10.1016\/j.diabres.2026.113210_b0080","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1161\/01.CIR.0000129772.26647.6F","article-title":"Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance","volume":"109","author":"De Jongh","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.diabres.2026.113210_b0085","doi-asserted-by":"crossref","first-page":"24397","DOI":"10.1038\/s41598-025-10230-8","article-title":"A prospective study on the role of non-invasive tests in the evaluation of diabetes mellitus associated steatotic liver disease","volume":"15","author":"\u0130stemihan","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.diabres.2026.113210_b0090","article-title":"Prediction of retinopathy risk: a prospective cohort study in China","volume":"103251","author":"Xu","year":"2025","journal-title":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews"},{"key":"10.1016\/j.diabres.2026.113210_b0095","article-title":"Dyslipidemia and its role in the pathogenesis of atherosclerotic cardiovascular disease: implications for evaluation and targets for treatment of dyslipidemia based on recent guidelines","author":"Wengrofsky","year":"2019","journal-title":"In: Dyslipidemia edn: IntechOpen"},{"key":"10.1016\/j.diabres.2026.113210_b0100","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2147\/IJNRD.S196841","article-title":"Hypertensive retinopathy and associated factors among nondiabetic chronic kidney disease patients seen at a tertiary hospital in Tanzania: a cross-sectional study","author":"Chillo","year":"2019","journal-title":"Int J Nephrol Renov Dis"},{"issue":"1","key":"10.1016\/j.diabres.2026.113210_b0105","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1186\/s12889-024-21117-0","article-title":"Association of retinal microvascular abnormalities with all-cause and specific-cause mortality among US adults","volume":"24","author":"Chen","year":"2024","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.diabres.2026.113210_b0110","doi-asserted-by":"crossref","first-page":"74","DOI":"10.34067\/KID.0003912021","article-title":"Albuminuria within the normal range can predict all-cause mortality and cardiovascular mortality","volume":"3","author":"Kang","year":"2022","journal-title":"Kidney360"},{"issue":"6","key":"10.1016\/j.diabres.2026.113210_b0115","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/aje\/kwm126","article-title":"Retinopathy and survival in a population without diabetes: the beaver dam eye study","volume":"166","author":"Hirai","year":"2007","journal-title":"Am J Epidemiol"},{"issue":"7","key":"10.1016\/j.diabres.2026.113210_b0120","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1212\/01.wnl.0000179177.15900.ca","article-title":"Retinal microvascular signs and risk of stroke and stroke mortality","volume":"65","author":"Mitchell","year":"2005","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.diabres.2026.113210_b0125","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1053\/j.ajkd.2010.04.013","article-title":"Predictors of incident albuminuria in the Framingham Offspring cohort","volume":"56","author":"O'Seaghdha","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.diabres.2026.113210_b0130","doi-asserted-by":"crossref","first-page":"457","DOI":"10.23736\/S0392-9590.21.04664-2","article-title":"Chronic venous disease and diabetic microangiopathy: pathophysiology and commonalities","volume":"40","author":"Gastaldi","year":"2021","journal-title":"Int Angiol"},{"issue":"4","key":"10.1016\/j.diabres.2026.113210_b0135","first-page":"457","article-title":"A review on cellular and molecular mechanisms linked to the development of diabetes complications","volume":"17","author":"Babel","year":"2021","journal-title":"Curr Diabetes Rev"},{"issue":"3","key":"10.1016\/j.diabres.2026.113210_b0140","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.15419\/bmrat.v8i3.663","article-title":"Pathophysiology of diabetes mellitus complications: metabolic events and control","volume":"8","author":"Ohiagu","year":"2021","journal-title":"Biomed Res Ther"},{"issue":"4","key":"10.1016\/j.diabres.2026.113210_b0145","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.tem.2020.01.007","article-title":"Chronic diabetes complications: the need to move beyond classical concepts","volume":"31","author":"Mauricio","year":"2020","journal-title":"Trends in Endocrinology & Metabolism"},{"issue":"2","key":"10.1016\/j.diabres.2026.113210_b0150","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4239\/wjd.v10.i2.63","article-title":"Insulin resistance is associated with subclinical vascular disease in humans","volume":"10","author":"Adeva-Andany","year":"2019","journal-title":"World J Diabetes"},{"key":"10.1016\/j.diabres.2026.113210_b0155","doi-asserted-by":"crossref","first-page":"890","DOI":"10.2741\/4758","article-title":"Mechanisms of obesity-induced metabolic and vascular dysfunctions","volume":"24","author":"Atawia","year":"2019","journal-title":"Frontiers in Bioscience (Landmark edition)"},{"issue":"4","key":"10.1016\/j.diabres.2026.113210_b0160","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3390\/medicina60040566","article-title":"Diabetes, hypertension and cardiovascular disease: clinical insights, mechanisms and pharmacotherapies","volume":"60","author":"Hung","year":"2024","journal-title":"Medicina"},{"issue":"1","key":"10.1016\/j.diabres.2026.113210_b0165","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s12964-022-01016-w","article-title":"Common mechanisms underlying diabetic vascular complications: focus on the interaction of metabolic disorders, immuno-inflammation, and endothelial dysfunction","volume":"21","author":"Xue","year":"2023","journal-title":"Cell Commun Signaling"},{"issue":"40","key":"10.1016\/j.diabres.2026.113210_b0170","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000035285","article-title":"Vascular complications of diabetes: a narrative review","volume":"102","author":"Lu","year":"2023","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.diabres.2026.113210_b0175","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3390\/cells9020464","article-title":"Characterizing the retinal phenotype in the high-fat diet and western diet mouse models of prediabetes","volume":"9","author":"Asare-Bediako","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.diabres.2026.113210_b0180","doi-asserted-by":"crossref","first-page":"19556","DOI":"10.1038\/s41598-019-55987-x","article-title":"Effects of different diets used in diet-induced obesity models on insulin resistance and vascular dysfunction in C57BL\/6 mice","volume":"9","author":"Lang","year":"2019","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.diabres.2026.113210_b0185","article-title":"Prevalence of retinopathy in prediabetic populations: a systematic review and meta-analysis","volume":"15","author":"Sune","year":"2023","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.diabres.2026.113210_b0190","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41392-025-02175-1","article-title":"Diabetic neuropathy: cutting-edge research and future directions","volume":"10","author":"Yang","year":"2025","journal-title":"Signal Transduct Target Ther"},{"issue":"11S","key":"10.1016\/j.diabres.2026.113210_b0195","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1681\/ASN.20223311S1582c","article-title":"Prevalence and awareness of kidney disease among individuals with prediabetes: FR-PO936","volume":"33","author":"Li","year":"2022","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.diabres.2026.113210_b0200","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1007\/s12325-022-02208-z","article-title":"The peripheral neuropathy prevalence and characteristics are comparable in people with obesity and long-duration type 1 diabetes","volume":"39","author":"Lim","year":"2022","journal-title":"Adv Ther"},{"issue":"Suppl_1","key":"10.1016\/j.diabres.2026.113210_b0205","doi-asserted-by":"crossref","DOI":"10.1161\/circ.150.suppl_1.4147574","article-title":"Prevalence of albuminuria in US adults: 2017-2020","volume":"150","author":"Kibbi","year":"2024","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.diabres.2026.113210_b0210","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4103\/jfcm.jfcm_57_22","article-title":"Evaluation of microalbuminuria in obesity phenotypes","volume":"29","author":"Alagh","year":"2022","journal-title":"J Fam Community Med"},{"issue":"1","key":"10.1016\/j.diabres.2026.113210_b0215","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12902-022-00976-x","article-title":"Spot urinary microalbumin concentration, metabolic syndrome and type 2 diabetes: tehran lipid and glucose study","volume":"22","author":"Gaeini","year":"2022","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"10.1016\/j.diabres.2026.113210_b0220","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12902-020-00634-0","article-title":"Association of microalbuminuria with metabolic syndrome: a cross-sectional study in Bangladesh","volume":"20","author":"Saadi","year":"2020","journal-title":"BMC Endocr Disord"},{"issue":"5","key":"10.1016\/j.diabres.2026.113210_b0225","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.3390\/ijms26052174","article-title":"Link between metabolic syndrome, inflammation, and eye diseases","volume":"26","author":"Pie\u0144czykowska","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.diabres.2026.113210_b0230","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/HYPERTENSIONAHA.121.17323","article-title":"Albuminuria testing in hypertension and diabetes: an individual-participant data meta-analysis in a global consortium","volume":"78","author":"Shin","year":"2021","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.diabres.2026.113210_b0235","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40942-025-00631-2","article-title":"Prevalence of hypertensive retinopathy and its associated factors among adult hypertensive patients attending at Comprehensive Specialized Hospitals in Northwest Ethiopia, 2024, a multicenter cross-sectional study","volume":"11","author":"Gudayneh","year":"2025","journal-title":"International Journal of Retina and Vitreous"},{"issue":"2","key":"10.1016\/j.diabres.2026.113210_b0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0318736","article-title":"Association between cardiometabolic index and albuminuria: evidence from NHANES 2017\u20132020","volume":"20","author":"Xu","year":"2025","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.diabres.2026.113210_b0245","doi-asserted-by":"crossref","first-page":"30960","DOI":"10.1038\/s41598-024-82084-5","article-title":"Association between triglyceride to high-density lipoprotein cholesterol ratio and microalbuminuria in the chinese population","volume":"14","author":"Zhang","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.diabres.2026.113210_b0250","doi-asserted-by":"crossref","first-page":"14870","DOI":"10.1038\/s41598-024-65037-w","article-title":"Urinary albumin creatinine ratio is associated with lipid profile","volume":"14","author":"Hwang","year":"2024","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.diabres.2026.113210_b0255","first-page":"1754","article-title":"The prevention opportunities of retinopathy in diabetic patients\u2013position paper endorsed by the Polish Lipid Association","volume":"20","author":"Banach","year":"2024","journal-title":"Arch Med Sci"},{"issue":"5","key":"10.1016\/j.diabres.2026.113210_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2024.101512","article-title":"MAFLD criteria are better than MASLD criteria at predicting the risk of chronic kidney disease","volume":"29","author":"Pan","year":"2024","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.diabres.2026.113210_b0265","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1147458","article-title":"Non-alcoholic fatty liver disease and incidence of microvascular complications of diabetes in patients with type 2 diabetes: a prospective cohort study","volume":"14","author":"Deravi","year":"2023","journal-title":"Front Endocrinol"},{"issue":"4","key":"10.1016\/j.diabres.2026.113210_b0270","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/hr.2009.228","article-title":"Macrovascular and microvascular dysfunction in the metabolic syndrome","volume":"33","author":"Czernichow","year":"2010","journal-title":"Hypertens Res"},{"issue":"4","key":"10.1016\/j.diabres.2026.113210_b0275","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.numecd.2023.11.011","article-title":"Liver fibrosis, NT-ProBNP and mortality in patients with MASLD: a population-based cohort study","volume":"34","author":"Ciardullo","year":"2024","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"10.1016\/j.diabres.2026.113210_b0280","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s12933-022-01697-0","article-title":"Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention","volume":"21","author":"Zhou","year":"2022","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"10.1016\/j.diabres.2026.113210_b0285","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.5551\/jat.63317","article-title":"Mild hypertensive retinopathy and risk of cardiovascular disease: the suita study","volume":"29","author":"Li","year":"2022","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.diabres.2026.113210_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcrp.2023.200180","article-title":"Hypertensive retinopathy and cardiovascular disease risk: 6 population-based cohorts meta-analysis","volume":"17","author":"Liew","year":"2023","journal-title":"International Journal of Cardiology Cardiovascular Risk and Prevention"},{"key":"10.1016\/j.diabres.2026.113210_b0295","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijcard.2023.01.079","article-title":"Endothelial dysfunction predicts bleeding and cardiovascular death in acute coronary syndrome","volume":"376","author":"Yoshii","year":"2023","journal-title":"Int J Cardiol"},{"issue":"9","key":"10.1016\/j.diabres.2026.113210_b0300","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/aje\/kwaa023","article-title":"Microvascular phenotyping in the Maastricht Study: design and main findings, 2010\u20132018","volume":"189","author":"Li","year":"2020","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.diabres.2026.113210_b0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-018-0703-2","article-title":"Diabetes, cardiovascular disease and the microcirculation","volume":"17","author":"Strain","year":"2018","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"10.1016\/j.diabres.2026.113210_b0310","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1559-4572.2009.00054.x","article-title":"Pathogenesis and pathophysiology of the cardiometabolic syndrome","volume":"11","author":"Kirk","year":"2009","journal-title":"The Journal of Clinical Hypertension"},{"key":"10.1016\/j.diabres.2026.113210_b0315","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejim.2023.11.005","article-title":"Natural history of metabolic dysfunction-associated steatotic liver disease","volume":"122","author":"Lekakis","year":"2024","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.diabres.2026.113210_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2019.153988","article-title":"Supervised lifestyle intervention for people with metabolic syndrome improves outcomes and reduces individual risk factors of metabolic syndrome: a systematic review and meta-analysis","volume":"101","author":"van Namen","year":"2019","journal-title":"Metabolism"},{"issue":"7","key":"10.1016\/j.diabres.2026.113210_b0325","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2174\/0929867326666190903112146","article-title":"Endothelial dysfunction in dyslipidaemia: Molecular mechanisms and clinical implications","volume":"27","author":"Zaric","year":"2020","journal-title":"Curr Med Chem"},{"issue":"24","key":"10.1016\/j.diabres.2026.113210_b0330","doi-asserted-by":"crossref","first-page":"15722","DOI":"10.3390\/ijms232415722","article-title":"Endothelial dysfunction and chronic inflammation: the cornerstones of vascular alterations in age-related diseases","volume":"23","author":"Pacinella","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.diabres.2026.113210_b0335","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s12272-019-01130-3","article-title":"Recent advances in the pathogenesis of microvascular complications in diabetes","volume":"42","author":"Park","year":"2019","journal-title":"Arch Pharm Res"},{"issue":"6","key":"10.1016\/j.diabres.2026.113210_b0340","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.3390\/jcm9061995","article-title":"Oxidative stress and new pathogenetic mechanisms in endothelial dysfunction: potential diagnostic biomarkers and therapeutic targets","volume":"9","author":"Scioli","year":"2020","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.diabres.2026.113210_b0345","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1210\/endrev\/bnaa025","article-title":"Microvascular dysfunction in diabetes mellitus and cardiometabolic disease","volume":"42","author":"Horton","year":"2021","journal-title":"Endocr Rev"},{"key":"10.1016\/j.diabres.2026.113210_b0350","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00917.2020","article-title":"Mitochondrial contributions to vascular endothelial dysfunction, arterial stiffness, and cardiovascular diseases","author":"Kirkman","year":"2021","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"key":"10.1016\/j.diabres.2026.113210_b0355","article-title":"The impact of oxidative stress-induced mitochondrial dysfunction on diabetic microvascular complications","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.diabres.2026.113210_b0360","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3389\/fphys.2020.00472","article-title":"Oxidative stress and microvessel barrier dysfunction","volume":"11","author":"He","year":"2020","journal-title":"Front Physiol"},{"issue":"19","key":"10.1016\/j.diabres.2026.113210_b0365","doi-asserted-by":"crossref","first-page":"7315","DOI":"10.1074\/jbc.RA117.001254","article-title":"Mitochondrial oxidative stress causes insulin resistance without disrupting oxidative phosphorylation","volume":"293","author":"Fazakerley","year":"2018","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.diabres.2026.113210_b0370","first-page":"789","article-title":"Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice","volume":"118","author":"Bonnard","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabres.2026.113210_b0375","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.966590","article-title":"Circulating and dietary advanced glycation end products and obesity in an adult population: a paradox of their detrimental effects in obesity","volume":"13","author":"Turki Jalil","year":"2022","journal-title":"Front Endocrinol"},{"issue":"1","key":"10.1016\/j.diabres.2026.113210_b0380","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12902-023-01520-1","article-title":"Soluble receptor for advanced glycation end products (sRAGE) is associated with obesity rates: a systematic review and meta-analysis of cross-sectional study","volume":"23","author":"Tayyib","year":"2023","journal-title":"BMC Endocr Disord"},{"issue":"3","key":"10.1016\/j.diabres.2026.113210_b0385","doi-asserted-by":"crossref","DOI":"10.17219\/acem\/112611","article-title":"Advanced glycation end products derived from serum albumin modification by glucose (AGE-1) reflect clustering of lipid-associated metabolic abnormalities and are decreased in patients treated with acarbose: a cross-sectional study","volume":"29","author":"Bronowicka-Szyde\u0142ko","year":"2020","journal-title":"Advances in Clinical & Experimental Medicine"},{"issue":"1","key":"10.1016\/j.diabres.2026.113210_b0390","doi-asserted-by":"crossref","first-page":"18722","DOI":"10.1038\/s41598-024-69822-5","article-title":"Correlation between serum advanced glycation end-products and vascular complications in patient with type 2 diabetes","volume":"14","author":"Kato","year":"2024","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.diabres.2026.113210_b0395","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3390\/biom12040542","article-title":"Advanced glycation end products and diabetes mellitus: mechanisms and perspectives","volume":"12","author":"Khalid","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.diabres.2026.113210_b0400","first-page":"1","article-title":"AGE-RAGE axis and cardiovascular diseases: pathophysiologic mechanisms and prospects for clinical applications","author":"Wang","year":"2024","journal-title":"Cardiovasc Drugs Ther"},{"issue":"1","key":"10.1016\/j.diabres.2026.113210_b0405","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-22-0271","article-title":"Immunology of chronic low-grade inflammation: relationship with metabolic function","volume":"257","author":"Van de Vyver","year":"2023","journal-title":"J Endocrinol"},{"issue":"24","key":"10.1016\/j.diabres.2026.113210_b0410","doi-asserted-by":"crossref","first-page":"13471","DOI":"10.3390\/ijms222413471","article-title":"Inflammation in coronary microvascular dysfunction","volume":"22","author":"Sagris","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.diabres.2026.113210_b0415","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1161\/HYPERTENSIONAHA.121.17955","article-title":"Immune system and microvascular remodeling in humans","volume":"79","author":"Rizzoni","year":"2022","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.diabres.2026.113210_b0420","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.3390\/ijms22126341","article-title":"Endothelial cell participation in inflammatory reaction","volume":"22","author":"Wautier","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.diabres.2026.113210_b0425","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1016\/j.dsx.2019.06.005","article-title":"An update on metabolic syndrome: metabolic risk markers and adipokines in the development of metabolic syndrome","volume":"13","author":"Kumari","year":"2019","journal-title":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews"},{"issue":"10","key":"10.1016\/j.diabres.2026.113210_b0430","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1172\/JCI129187","article-title":"Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome","volume":"129","author":"Kahn","year":"2019","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.diabres.2026.113210_b0435","first-page":"C375","article-title":"Adipose tissue inflammation and metabolic dysfunction in obesity","volume":"320","author":"Kawai","year":"2021","journal-title":"Am J Phys Cell Phys"},{"issue":"6","key":"10.1016\/j.diabres.2026.113210_b0440","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.3390\/cells10061485","article-title":"Role of perivascular adipose tissue-derived adiponectin in vascular homeostasis","volume":"10","author":"Sowka","year":"2021","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.diabres.2026.113210_b0445","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.3390\/ijms25052973","article-title":"New insights into endothelial dysfunction in cardiometabolic diseases: potential mechanisms and clinical implications","volume":"25","author":"Gallo","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.diabres.2026.113210_b0450","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1186\/s12933-024-02549-9","article-title":"Perivascular adipose tissue: a central player in the triad of diabetes, obesity, and cardiovascular health","volume":"23","author":"Queiroz","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2026.113210_b0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102683","article-title":"Perivascular adipose tissue: fine-tuner of vascular redox status and inflammation","volume":"62","author":"Cheng","year":"2023","journal-title":"Redox Biol"},{"issue":"1","key":"10.1016\/j.diabres.2026.113210_b0460","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1590\/1806-9282.65.1.87","article-title":"Central role of obesity in endothelial cell dysfunction and cardiovascular risk","volume":"65","author":"Lima","year":"2019","journal-title":"Revista da Associa\u00e7\u00e3o M\u00e9dica Brasileira"},{"issue":"2","key":"10.1016\/j.diabres.2026.113210_b0465","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2463\/mrms.rev.2021-0018","article-title":"Hemodynamic forces, endothelial mechanotransduction, and vascular diseases","volume":"21","author":"Ando","year":"2022","journal-title":"Magn Reson Med Sci"},{"issue":"2","key":"10.1016\/j.diabres.2026.113210_b0470","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3390\/ijms23020847","article-title":"Skeletal muscle microvascular dysfunction in obesity-related insulin resistance: pathophysiological mechanisms and therapeutic perspectives","volume":"23","author":"Ugwoke","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.diabres.2026.113210_b0475","doi-asserted-by":"crossref","first-page":"H1231","DOI":"10.1152\/ajpheart.00537.2022","article-title":"New insights into mechanisms of endothelial insulin resistance in type 2 diabetes","volume":"323","author":"Padilla","year":"2022","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"key":"10.1016\/j.diabres.2026.113210_b0480","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.836680","article-title":"Haemodynamic wall shear stress, endothelial permeability and atherosclerosis\u2014A triad of controversy","volume":"10","author":"Weinberg","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"issue":"21","key":"10.1016\/j.diabres.2026.113210_b0485","doi-asserted-by":"crossref","first-page":"8255","DOI":"10.3390\/ijms21218255","article-title":"Peritubular capillary rarefaction: an underappreciated regulator of CKD progression","volume":"21","author":"Kida","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.diabres.2026.113210_b0490","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-3-030-47801-8_12","article-title":"Microvascular alterations in diabetes: focus on small resistance arteries","author":"De Ciuceis","year":"2020","journal-title":"Microcirculation in Cardiovascular Diseases"},{"issue":"2","key":"10.1016\/j.diabres.2026.113210_b0495","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/jvim.16656","article-title":"Assessment of peritubular capillary rarefaction in kidneys of cats with chronic kidney disease","volume":"37","author":"Paschall","year":"2023","journal-title":"J Vet Intern Med"},{"issue":"6","key":"10.1016\/j.diabres.2026.113210_b0500","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ajpath.2024.01.019","article-title":"Ferroptosis contributes to microvascular dysfunction in diabetic retinopathy","volume":"194","author":"Liu","year":"2024","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.diabres.2026.113210_b0505","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2337\/dc21-1124","article-title":"Prediction of major adverse cardiovascular events from retinal, clinical, and genomic data in individuals with type 2 diabetes: a population cohort study","volume":"45","author":"Mordi","year":"2022","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.diabres.2026.113210_b0510","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0283083","article-title":"Association between urinary albumin creatinine ratio and cardiovascular disease","volume":"18","author":"Kim","year":"2023","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.diabres.2026.113210_b0515","first-page":"394","article-title":"Association of urine albumin excretion with incident heart failure hospitalization in community-dwelling adults. JACC","volume":"7","author":"Bailey","year":"2019","journal-title":"Heart Failure"},{"issue":"21","key":"10.1016\/j.diabres.2026.113210_b0520","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.3390\/cells11213363","article-title":"Clinical evaluation tool for vascular health\u2013endothelial function and cardiovascular disease management","volume":"11","author":"Wen","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.diabres.2026.113210_b0525","first-page":"9","article-title":"Therapeutic options targeting oxidative stress, mitochondrial dysfunction and inflammation to hinder the progression of vascular complications of diabetes","volume":"2019","author":"Teodoro","year":"1857","journal-title":"Front Physiol"},{"issue":"8","key":"10.1016\/j.diabres.2026.113210_b0530","doi-asserted-by":"crossref","first-page":"288","DOI":"10.31083\/j.rcm2508288","article-title":"Navigating the landscape of coronary microvascular research: trends, triumphs, and challenges ahead","volume":"25","author":"Wang","year":"2024","journal-title":"Rev Cardiovasc Med"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726001294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726001294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:38:33Z","timestamp":1793597913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822726001294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":106,"alternative-id":["S0168822726001294"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113210","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microvascular disease beyond diabetes: a metabolic continuum with implications for early detection and diabetes care","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113210","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113210"}}